Home About Events Press Room Contact Login
Global Insight // Bringing You the Power of Perspective
Healthcare & Pharma Industry Analysis
World Markets Healthcare
Pharmaceutical Pricing and Reimbursement Services
Oncology Pricing & Reimbursement Analysis
U.S. Healthcare Cost Service
European Pharmaceutical Market Data and Research
Healthcare Custom Solutions

Related Highlights
  How should Pharmaceutical Companies position themselves to handle the threat posed by biosimilars?
  14 Jan 08
Looking Back to the Future in the Global Pharma Market: Wrap-Up of 2007, Outlook for 2008
  7 Apr 06
Successfully developing Pharmaceuticals for the European Market


Global Insight's Healthcare and Pharmaceuticals practice provides an independent, comprehensive range of analysis, forecasts, data, and consulting services for:
  • Pharmaceutical manufacturers, wholesalers, and distributors
  • Biotechnology research and development firms
  • Generics manufacturers
  • Healthcare policy makers and regulatory bodies
  • Healthcare providers and insurers
  • Financial institutions and professional services organizations
We can provide you with timely, insightful, and accurate analysis on the evolving regulatory and competitive landscape in more than 60 countries worldwide—enabling you to:
  • Evaluate market opportunities and risks
  • Monitor competitors and customers
  • Assess the impact of a changing regulatory environment
  • Plan and forecast budgets
  • Stay up to date with recent industry developments and market trends
With our unique global perspective and regional expertise, we understand the forces in play—healthcare policy and regulatory developments, pharmaceutical pricing and reimbursement, industry-wide corporate strategies, and research and development trends,— and the ways they interact to influence your market opportunities.

Products and Services

Global Insight Healthcare and Pharmaceuticals Experts

Our expert team provides an independent, fact-based view of the healthcare and pharmaceutical industry, fully supported by our 325+ economists and analysts worldwide with expertise in over 120 industries and 200 countries.

Global Insight is the world leader in economic and financial analysis, forecasting, and market intelligence—with more than 40 years' experience and an outstanding record for accuracy.




Perspectives
13 May 08
GSK Starts Tykerb-Herceptin Head-to-Head Phase III Trial in Early Breast Cancer


12 May 08
Bayer Schering on High Alert as Barr Gains U.S. FDA Approval for Generic Yasmin


9 May 08
Takeda Reports High Profits But Forecasts Future Slump


8 May 08
Finnish Pharma Association Points Finger at P&R Body Over IP Rights


More 

International Web Site: Japan
 Copyright ©2008 GLOBAL INSIGHT, Inc. Site Map  •  Terms of Use  •  Privacy Policy